Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data | Blood Cancer Journal Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00665-x/MediaObjects/41408_2022_665_Fig1_HTML.png)
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data | Blood Cancer Journal
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data](https://becarispublishing.com/cms/10.2217/cer-2017-0100/asset/33d54716-29f3-4f24-9da6-6a9f1f5137a9/assets/images/large/figure1.jpg)
Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Characteristics for patients with multiple myeloma in 23 provinces in... | Download Scientific Diagram Characteristics for patients with multiple myeloma in 23 provinces in... | Download Scientific Diagram](https://www.researchgate.net/publication/338809885/figure/tbl1/AS:851033077071872@1579913505206/Characteristics-for-patients-with-multiple-myeloma-in-23-provinces-in-China-during.png)
Characteristics for patients with multiple myeloma in 23 provinces in... | Download Scientific Diagram
![Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0186-8/MediaObjects/41408_2019_186_Fig1_HTML.png)
Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal
![JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research](https://pub.mdpi-res.com/jcm/jcm-08-00999/article_deploy/html/images/jcm-08-00999-g001.png?1564597737)
JCM | Free Full-Text | Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research
![JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications](https://www.mdpi.com/jcm/jcm-12-01637/article_deploy/html/images/jcm-12-01637-g001.png)
JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications
![Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article](https://assets.cureus.com/uploads/figure/file/538389/lightbox_c8016ac09d1a11ed945b4115e58945c7-cureus.png)
Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article
![Frontiers | Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns Frontiers | Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns](https://www.frontiersin.org/files/Articles/537650/fcimb-10-537650-HTML/image_m/fcimb-10-537650-g001.jpg)
Frontiers | Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns
![Frontiers | Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy Frontiers | Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy](https://www.frontiersin.org/files/Articles/901266/fonc-12-901266-HTML-r1/image_m/fonc-12-901266-g001.jpg)